Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 2.020
0.00 (0.00%)
Sep 4, 2026, 5:29 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 490.32 million as of September 4, 2026. Its market cap has decreased by -15.83% in one year.
Market Cap
490.32M
Enterprise Value
491.35M
Revenue
51.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.02
ChartMarket Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 490.32M, an increase of 350.14%. That is a compound annual growth rate of 10.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 490.32M | 6.32% |
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.36B |
| Nanexa AB | 1.11B |
| Dicot Pharma AB | 830.40M |
| EQL Pharma AB | 782.53M |
| Cinclus Pharma Holding AB | 567.76M |
| Moberg Pharma AB | 540.69M |
| Orexo AB | 532.21M |
| Klaria Pharma Holding AB (publ.) | 155.70M |